- You can view the full Exact Sciences Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Exact Sciences (EXAS) stock is gaining on Monday after the National Committee for Quality Assurance updated its guidelines on colorectal cancer screening tests.